We seem to be bombarded almost daily by press releases from Biophan covering everything from their plans for the future to the CFO’s bowel movements (well, fortunately not quite). Since the onslaught began on August 11th we have received 14 releases though Business Wire (sometimes twice a day) and the companies stock price has plummeted by almost 20%.
Whether the media onslaught is shoring up or contributing to the decline in valuation we have no idea, but the volume of releases must be getting dangerously close to triggering our junk mail filters.